# Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)

> **NCT00264147** · PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 761 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** etoricoxib
- **DRUG:** etoricoxib
- **DRUG:** etoricoxib
- **DRUG:** etoricoxib
- **DRUG:** Comparator: placebo
- **DRUG:** etoricoxib
- **DRUG:** Comparator: diclofenac

## Key facts

- **NCT ID:** NCT00264147
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 761 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264147, "Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00264147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*